MYCN and neuroblastoma: However, when MG132 was used to slow the proteasomal degradation of ubiquitinated proteins, a massive increase in ubiquitinated forms of N-Myc was detected in AF1q-silenced Kelly cell extracts compared to control, indicating that AF1q prevents N-Myc ubiquitination in neuroblastoma.